BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 35093877)

  • 21. Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer.
    Hiroshima Y; Nakamura F; Miyamoto H; Mori R; Taniguchi K; Matsuyama R; Akiyama H; Tanaka K; Ichikawa Y; Kato S; Kobayashi N; Kubota K; Nagashima Y; Goshima Y; Endo I
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S369-78. PubMed ID: 22805864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer.
    Li C; Cui L; Yang L; Wang B; Zhuo Y; Zhang L; Wang X; Zhang Q; Zhang S
    Pancreas; 2020 Jan; 49(1):120-127. PubMed ID: 31856087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
    Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
    Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy.
    Rachagani S; Torres MP; Kumar S; Haridas D; Baine M; Macha MA; Kaur S; Ponnusamy MP; Dey P; Seshacharyulu P; Johansson SL; Jain M; Wagner KU; Batra SK
    J Hematol Oncol; 2012 Oct; 5():68. PubMed ID: 23102107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.
    Helm O; Held-Feindt J; Grage-Griebenow E; Reiling N; Ungefroren H; Vogel I; Krüger U; Becker T; Ebsen M; Röcken C; Kabelitz D; Schäfer H; Sebens S
    Int J Cancer; 2014 Aug; 135(4):843-61. PubMed ID: 24458546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer.
    Leal AS; Sporn MB; Pioli PA; Liby KT
    Carcinogenesis; 2016 Dec; 37(12):1170-1179. PubMed ID: 27659181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pancreatic cancer secreted REG4 promotes macrophage polarization to M2 through EGFR/AKT/CREB pathway.
    Ma X; Wu D; Zhou S; Wan F; Liu H; Xu X; Xu X; Zhao Y; Tang M
    Oncol Rep; 2016 Jan; 35(1):189-96. PubMed ID: 26531138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD163 Is Required for Protumoral Activation of Macrophages in Human and Murine Sarcoma.
    Shiraishi D; Fujiwara Y; Horlad H; Saito Y; Iriki T; Tsuboki J; Cheng P; Nakagata N; Mizuta H; Bekki H; Nakashima Y; Oda Y; Takeya M; Komohara Y
    Cancer Res; 2018 Jun; 78(12):3255-3266. PubMed ID: 29610117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the Pancreas.
    Smith JP; Cao H; Edmondson EF; Dasa SSK; Stern ST
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress induced by inactivation of TP53INP1 cooperates with KrasG12D to initiate and promote pancreatic carcinogenesis in the murine pancreas.
    Al Saati T; Clerc P; Hanoun N; Peuget S; Lulka H; Gigoux V; Capilla F; Béluchon B; Couvelard A; Selves J; Buscail L; Carrier A; Dusetti N; Dufresne M
    Am J Pathol; 2013 Jun; 182(6):1996-2004. PubMed ID: 23578383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of neuropeptide Y and its receptors Y1 and Y2 in pancreatic intraepithelial neoplasia and invasive pancreatic cancer in a transgenic mouse model and human samples of pancreatic cancer.
    Waldmann J; Fendrich V; Reichert M; Hecker A; Bartsch DK; Padberg W; Holler JPN
    J Surg Res; 2018 Mar; 223():230-236. PubMed ID: 29433879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requirement of NEMO/IKKγ for effective expansion of KRAS-induced precancerous lesions in the pancreas.
    Maier HJ; Wagner M; Schips TG; Salem HH; Baumann B; Wirth T
    Oncogene; 2013 May; 32(21):2690-5. PubMed ID: 22751123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma.
    Zhao F; Obermann S; von Wasielewski R; Haile L; Manns MP; Korangy F; Greten TF
    Immunology; 2009 Sep; 128(1):141-9. PubMed ID: 19689743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pomalidomide Alters Pancreatic Macrophage Populations to Generate an Immune-Responsive Environment at Precancerous and Cancerous Lesions.
    Bastea LI; Liou GY; Pandey V; Fleming AK; von Roemeling CA; Doeppler H; Li Z; Qiu Y; Edenfield B; Copland JA; Tun HW; Storz P
    Cancer Res; 2019 Apr; 79(7):1535-1548. PubMed ID: 30696657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of natural killer T cells promotes pancreatic cancer in LSL-Kras
    Janakiram NB; Mohammed A; Bryant T; Ritchie R; Stratton N; Jackson L; Lightfoot S; Benbrook DM; Asch AS; Lang ML; Rao CV
    Immunology; 2017 Sep; 152(1):36-51. PubMed ID: 28419443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
    Medrek C; Pontén F; Jirström K; Leandersson K
    BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteasome activity is required for the initiation of precancerous pancreatic lesions.
    Furuyama T; Tanaka S; Shimada S; Akiyama Y; Matsumura S; Mitsunori Y; Aihara A; Ban D; Ochiai T; Kudo A; Fukamachi H; Arii S; Kawaguchi Y; Tanabe M
    Sci Rep; 2016 May; 6():27044. PubMed ID: 27244456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD205
    Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S
    Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.
    Lan C; Huang X; Lin S; Huang H; Cai Q; Wan T; Lu J; Liu J
    Technol Cancer Res Treat; 2013 Jun; 12(3):259-67. PubMed ID: 23289476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Importance of a Conjoint Analysis of Tumor-Associated Macrophages and Immune Checkpoints in Pancreatic Cancer.
    Xu JY; Wang WS; Zhou J; Liu CY; Shi JL; Lu PH; Ding JL
    Pancreas; 2019 Aug; 48(7):904-912. PubMed ID: 31268976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.